𝔖 Bobbio Scriptorium
✦   LIBER   ✦

LONG-TERM INTERFERON THERAPY FOR THROMBOCYTOSIS IN MYELOPROLIFERATIVE DISEASES

✍ Scribed by Gisslinger, H.; Linkesch, W.; Fritz, E.; Ludwig, H.; Chott, A.; Radaszkiewicz, TH.


Book ID
122023978
Publisher
The Lancet
Year
1989
Tongue
English
Weight
535 KB
Volume
333
Category
Article
ISSN
0140-6736

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Long term treatment of myeloproliferativ
✍ Harriet S. Gilbert πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 96 KB

## BACKGROUND. Recombinant interferon-␣-2b (rIFN-␣-2b) has shown therapeutic potential in patients with chronic myelogenous leukemia and other myeloproliferative disorders (MPDs), including the ability to suppress the abnormal hematopoietic clone and to reverse myelofibrosis. This study was conduc